Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:261-268
Published online before print June 26, 2008, doi: 10.1161/CIRCRESAHA.108.174128
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/3/261    most recent
CIRCRESAHA.108.174128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishi, J.-i.
Right arrow Articles by Komuro, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishi, J.-i.
Right arrow Articles by Komuro, I.
Related Collections
Right arrow Angiogenesis
Right arrow Growth factors/cytokines
Right arrow Other Vascular biology
(Circulation Research. 2008;103:261.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Vascular Endothelial Growth Factor Receptor-1 Regulates Postnatal Angiogenesis Through Inhibition of the Excessive Activation of Akt

Jun-ichiro Nishi*, Tohru Minamino*, Hideyuki Miyauchi, Aika Nojima, Kaoru Tateno, Sho Okada, Masayuki Orimo, Junji Moriya, Guo-Hua Fong, Kenji Sunagawa, Masabumi Shibuya, Issei Komuro

From the Department of Cardiovascular Science and Medicine (J.N., T.M., H.M., A.N., K.T., S.O., M.O., J.M., I.K.), Chiba University Graduate School of Medicine, Japan; PRESTO (T.M.), Japan Science and Technology Agency, Saitama, Japan; the Department of Physiology (G.-H.F.), University of Connecticut Health Center, Farmington; the Department of Cardiovascular Medicine (J.N., K.S.), Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; and the Department of Molecular Oncology (M.S.), Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, Japan.

Correspondence to Issei Komuro, MD, PhD, Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail komuro-tky{at}umin.ac.jp

Vascular endothelial growth factor (VEGF) binds both VEGF receptor-1 (VEGFR-1) and VEGF receptor-2 (VEGFR-2). Activation of VEGFR-2 is thought to play a major role in the regulation of endothelial function by VEGF. Recently, specific ligands for VEGFR-1 have been reported to have beneficial effects when used to treat ischemic diseases. However, the role of VEGFR-1 in angiogenesis is not fully understood. In this study, we showed that VEGFR-1 performs "fine tuning" of VEGF signaling to induce neovascularization. We examined the effects of retroviral vectors expressing a small interference RNA that targeted either the VEGFR-1 gene or the VEGFR-2 gene. Deletion of either VEGFR-1 or VEGFR-2 reduced the ability of endothelial cells to form capillaries. Deletion of VEGFR-1 markedly reduced endothelial cell proliferation and induced premature senescence of endothelial cells. In contrast, deletion of VEGFR-2 significantly impaired endothelial cell survival. When VEGFR-1 expression was blocked, VEGF constitutively activated Akt signals and thus induced endothelial cell senescence via a p53-dependent pathway. VEGFR-1+/– mice exhibited an increase of endothelial Akt activity and showed an impaired neovascularization in response to ischemia, and this impairment was ameliorated in VEGFR-1+/– Akt1+/– mice. These results suggest that VEGFR-1 plays a critical role in the maintenance of endothelial integrity by modulating the VEGF/Akt signaling pathway.


Key Words: VEGF • Akt • senescence • p53




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet
Role and Therapeutic Potential of VEGF in the Nervous System
Physiol Rev, April 1, 2009; 89(2): 607 - 648.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C.-Y. Wang, H.-H. Kim, Y. Hiroi, N. Sawada, S. Salomone, L. E. Benjamin, K. Walsh, M. A. Moskowitz, and J. K. Liao
Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR
Sci. Signal., March 17, 2009; 2(62): ra11 - ra11.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ponticelli, D. Marasco, V. Tarallo, R. J. C. Albuquerque, S. Mitola, A. Takeda, J.-M. Stassen, M. Presta, J. Ambati, M. Ruvo, et al.
Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1
J. Biol. Chem., December 5, 2008; 283(49): 34250 - 34259.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-Y. Wang, M.-S. Wen, H.-W. Wang, I-C. Hsieh, Y. Li, P.-Y. Liu, F.-C. Lin, and J. K. Liao
Increased Vascular Senescence and Impaired Endothelial Progenitor Cell Function Mediated by Mutation of Circadian Gene Per2
Circulation, November 18, 2008; 118(21): 2166 - 2173.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. K. Liao
Fine-Tuning the Angiogenic Response to Vascular Endothelial Growth Factor
Circ. Res., August 1, 2008; 103(3): 229 - 230.
[Full Text] [PDF]